These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 35863460)

  • 1. SARS-CoV-2 immunoglobulin G antibody levels in infants following messenger RNA COVID-19 vaccination during pregnancy.
    Kugelman N; Nahshon C; Shaked-Mishan P; Lavie O; Stein N; Kedar R; Waisman D
    Am J Obstet Gynecol; 2022 Dec; 227(6):911-913. PubMed ID: 35863460
    [No Abstract]   [Full Text] [Related]  

  • 2. Third trimester messenger RNA COVID-19 booster vaccination upsurge maternal and neonatal SARS-CoV-2 immunoglobulin G antibody levels at birth.
    Kugelman N; Nahshon C; Shaked-Mishan P; Cohen N; Lahav Sher M; Barsha H; Shalabna E; Zolotarevsky A; Lavie O; Kedar R; Riskin-Mashiah S
    Eur J Obstet Gynecol Reprod Biol; 2022 Jul; 274():148-154. PubMed ID: 35653903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19?
    Scaggs Huang F
    J Pediatric Infect Dis Soc; 2022 Apr; 11(4):126. PubMed ID: 35394545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal and Neonatal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G Levels After the Pfizer-BioNTech Booster Dose for Coronavirus Disease 2019 (COVID-19) Vaccination During the Second Trimester of Pregnancy.
    Kugelman N; Nahshon C; Shaked-Mishan P; Kleifeld S; Cohen N; Sher ML; Zahran H; Barsha H; Assaf W; Shalabna E; Stein N; Lavie O; Kedar R; Riskin-Mashiah S
    Obstet Gynecol; 2022 Aug; 140(2):187-193. PubMed ID: 35852268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient Maternofetal Transplacental Transfer of Anti- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Antibodies After Antenatal SARS-CoV-2 BNT162b2 Messenger RNA Vaccination.
    Rottenstreich A; Zarbiv G; Oiknine-Djian E; Zigron R; Wolf DG; Porat S
    Clin Infect Dis; 2021 Nov; 73(10):1909-1912. PubMed ID: 33822014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies among parturient women treated with BNT162b2 messenger RNA vaccine during pregnancy.
    Nir O; Schwartz A; Toussia-Cohen S; Leibovitch L; Strauss T; Asraf K; Doolman R; Sharabi S; Cohen C; Lustig Y; Regev-Yochay G; Yinon Y
    Am J Obstet Gynecol MFM; 2022 Jan; 4(1):100492. PubMed ID: 34547533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boosting maternal and neonatal humoral immunity following SARS-CoV-2 infection using a single messenger RNA vaccine dose.
    Nevo L; Cahen-Peretz A; Vorontsov O; Frenkel R; Kabessa M; Cohen SM; Hamrani A; Oiknine-Djian E; Lipschuetz M; Goldman-Wohl D; Walfisch A; Kovo M; Neeman M; Yagel S; Wolf DG; Beharier O
    Am J Obstet Gynecol; 2022 Sep; 227(3):486.e1-486.e10. PubMed ID: 35430228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe Acute Respiratory Syndrome Coronavirus 2 Infection Versus Vaccination in Pregnancy: Implications for Maternal and Infant Immunity.
    Conti MG; Terreri S; Terrin G; Natale F; Pietrasanta C; Salvatori G; Brunelli R; Midulla F; Papaevangelou V; Carsetti R; Angelidou A
    Clin Infect Dis; 2022 Aug; 75(Suppl 1):S37-S45. PubMed ID: 35535796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Gestational Age at BNT162b2 mRNA Vaccination on Maternal and Neonatal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Levels.
    Rottenstreich A; Zarbiv G; Oiknine-Djian E; Vorontsov O; Zigron R; Kleinstern G; Wolf DG; Porat S
    Clin Infect Dis; 2022 Aug; 75(1):e603-e610. PubMed ID: 35171998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 mRNA Vaccination in Lactation: Assessment of Adverse Events and Vaccine Related Antibodies in Mother-Infant Dyads.
    Golan Y; Prahl M; Cassidy AG; Gay C; Wu AHB; Jigmeddagva U; Lin CY; Gonzalez VJ; Basilio E; Chidboy MA; Warrier L; Buarpung S; Li L; Murtha AP; Asiodu IV; Ahituv N; Flaherman VJ; Gaw SL
    Front Immunol; 2021; 12():777103. PubMed ID: 34804068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal and Neonatal SARS-CoV-2 Immunoglobulin G Antibody Levels at Delivery After Receipt of the BNT162b2 Messenger RNA COVID-19 Vaccine During the Second Trimester of Pregnancy.
    Kugelman N; Nahshon C; Shaked-Mishan P; Cohen N; Sher ML; Gruber M; Marom I; Zolotarevsky A; Lavie O; Damti A; Zilberlicht A; Bardicef M; Kedar R
    JAMA Pediatr; 2022 Mar; 176(3):290-295. PubMed ID: 34932066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-SARS-CoV-2 IgA and IgG in human milk after vaccination is dependent on vaccine type and previous SARS-CoV-2 exposure: a longitudinal study.
    Selma-Royo M; Bäuerl C; Mena-Tudela D; Aguilar-Camprubí L; Pérez-Cano FJ; Parra-Llorca A; Lerin C; Martínez-Costa C; Collado MC
    Genome Med; 2022 Apr; 14(1):42. PubMed ID: 35449030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of Maternal Antibodies Elicited by COVID-19 Vaccination in Amniotic Fluid: Report of Two Cases in Italy.
    Colavita F; Oliva A; Bettini A; Antinori A; Girardi E; Castilletti C; Vaia F; Liuzzi G
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery.
    Yang YJ; Murphy EA; Singh S; Sukhu AC; Wolfe I; Adurty S; Eng D; Yee J; Mohammed I; Zhao Z; Riley LE; Prabhu M
    Obstet Gynecol; 2022 Mar; 139(3):373-380. PubMed ID: 34963127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of SARS-CoV-2 antibodies in lactating women and their infants following BNT162b2 messenger RNA vaccine.
    Schwartz A; Nir O; Toussia-Cohen S; Leibovich L; Strauss T; Asraf K; Doolman R; Sharabi S; Cohen C; Levin EG; Lustig Y; Regev-Yochay G; Yinon Y
    Am J Obstet Gynecol; 2021 Nov; 225(5):577-579. PubMed ID: 34352250
    [No Abstract]   [Full Text] [Related]  

  • 16. SARS-CoV-2 infection long time after full vaccination is related to a lack of neutralizing antibodies.
    Alidjinou EK; Gaillot O; Guigon A; Tinez C; Lazrek M; Bocket L; Engelmann I; Hober D
    Diagn Microbiol Infect Dis; 2022 Jan; 102(1):115565. PubMed ID: 34731684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Maternal SARS-CoV-2 Infection or SARS-CoV-2 Vaccination Trigger an Inflammatory Response in the Fetus? A Prospective Cohort Study.
    Alhousseini A; Turkoglu O; Sajja S; Wharton K; Idler J; Bahado-Singh R
    Gynecol Obstet Invest; 2022; 87(3-4):219-225. PubMed ID: 35728583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-vaccination SARS-CoV-2 seroprevalence in children aged 3-11 years and the positivity in unvaccinated children: A retrospective, single-center study.
    Li J; Ge M; Dai S; Song Q; Liu W; Wang Y; Xu W; Ma L
    Front Immunol; 2022; 13():1030238. PubMed ID: 36420275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies Against SARS-CoV-2 in Human Breast Milk After Vaccination: A Systematic Review and Meta-Analysis.
    Whited N; Cervantes J
    Breastfeed Med; 2022 Jun; 17(6):475-483. PubMed ID: 35325550
    [No Abstract]   [Full Text] [Related]  

  • 20. Longitudinal serologic and viral testing post-SARS-CoV-2 infection and post-receipt of mRNA COVID-19 vaccine in a nursing home cohort-Georgia, October 2020‒April 2021.
    Tobolowsky FA; Waltenburg MA; Moritz ED; Haile M; DaSilva JC; Schuh AJ; Thornburg NJ; Westbrook A; McKay SL; LaVoie SP; Folster JM; Harcourt JL; Tamin A; Stumpf MM; Mills L; Freeman B; Lester S; Beshearse E; Lecy KD; Brown LG; Fajardo G; Negley J; McDonald LC; Kutty PK; Brown AC;
    PLoS One; 2022; 17(10):e0275718. PubMed ID: 36301805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.